FCX vs ITRM · P/E 38, rev $25.45B vs rev $390.0K
Freeport-McMoran Copper & Gold Inc (FCX) versus Iterum Therapeutics PLC (ITRM) — a side-by-side from cached financials, not a winner call.
Freeport-McMoran Copper & Gold Inc (FCX) is a copper company listed on US.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
Latest reported FCX revenue for 2024-12-31 was $25.45B. Net income was $4.40B. Revenue was up 11.4% from 2023-12-31 to 2024-12-31. FCX currently screens at market cap $67.80B and trailing P/E 38.0.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
FCX currently screens at market cap $67.80B and trailing P/E 38.0. ITRM currently screens at market cap $38.6M.
Not investment advice. Open the FCX and ITRM stock pages for the full models.
Not investment advice.